Skip to content

Lumbar Plexus and Suprainguinal Fascia Iliaca Blocks For Total Hip Replacement

A Randomized Comparison Between Ultrasound Guided Lumbar Plexus and Suprainguinal Fascia Iliaca Blocks For Total Hip Replacement Analgesia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03744065
Enrollment
60
Registered
2018-11-16
Start date
2018-11-19
Completion date
2020-01-23
Last updated
2020-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Osteoarthritis, Pain, Acute, Pain, Postoperative, Opioid Use

Keywords

nerve block, fascia iliaca, hip replacement, lumbar plexus

Brief summary

The nerves from lumbar plexus (LP) are the current target to achieve analgesia after a total hip arthroplasty (THA). Lumbar plexus block (LPB) is an alternative that provides optimal postoperative analgesia. However, many adverse effects and complications have been reported due to its proximity to vital structures. Because of these shortcomings, an alternative to block the LP nerves is required. In a recent trial suprainguinal Fascia Iliaca Block (SFIB) was reported to provide reliable analgesia in THA. SFIB may carry a lower risk profile, however, no study has compared the efficacy of LPB and SFIB in this setting. Thus, this randomized trial is set out to compare US guided LPB and SFIB for analgesia after THA. The hypothesis is that both blocks would result in similar postoperative opioid (morphine) consumption at 24 hours and, therefore, designed the study as an equivalence trial.

Interventions

Injection with ultrasound guidance of 40 mL of levobupivacaine 0.25% with 5 micrograms of epinephrine per mL and dexamethasone 4 milligrams, in the posteromedial quadrant of psoas muscle

Injection with ultrasound guidance of 40 mL of levobupivacaine 0.25% with 5 micrograms of epinephrine per mL and dexamethasone 4 milligrams, underneath the fascia iliaca at the suprainguinal level

Sponsors

University of Chile
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18 and 80 years * American Society of Anesthesiologists classification 1-3 * Body mass index between 20 and 35 (kg/m2)

Exclusion criteria

* Adults who are unable to give their own consent * Pre-existing neuropathy (assessed by history and physical examination) * Coagulopathy (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. platelets ≤ 100, International Normalized Ratio ≥ 1.4 or prothrombin time ≥ 50) * Renal failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. creatinine ≥ 100) * Hepatic failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. transaminases ≥ 100) * Allergy to local anesthetics (LAs) or morphine * Pregnancy * Prior surgery in the corresponding side of the lumbar o suprainguinal area * Chronic pain syndromes requiring opioid intake at home

Design outcomes

Primary

MeasureTime frameDescription
Morphine consumption over 24 hours24 hours post blockTotal morphine consumption over 24 hours post block

Secondary

MeasureTime frameDescription
Postoperative static pain at 12 hours after block12 hours after the blockPain evaluated in Numeric Rating Score from 0 to 10 points
Postoperative static pain at 24 hours after block24 hours after the blockPain evaluated in Numeric Rating Score from 0 to 10 points
Postoperative dynamic pain at 3 hours after block3 hours after the blockPain evaluated in Numeric Rating Score from 0 to 10 points
Postoperative dynamic pain at 6 hours after block6 hours after the blockPain evaluated in Numeric Rating Score from 0 to 10 points
Performance time2 hours after surgeryInterval between the start of skin disinfection and the end of local anesthetic injection
Number of needle passes2 hours after surgeryThe initial needle insertion counted as the first pass. Any subsequent needle advancement that is preceded by a retraction of at least 10 mm counts as an additional pass
Postoperative static pain at 3 hours after block3 hours after the blockPain evaluated in Numeric Rating Score from 0 to 10 points
Postoperative dynamic pain at 12 hours after block12 hours after the blockPain evaluated in Numeric Rating Score from 0 to 10 points
Postoperative dynamic pain at 24 hours after block24 hours after the blockPain evaluated in Numeric Rating Score from 0 to 10 points
Postoperative static pain at 48 hours after block48 hours after the blockPain evaluated in Numeric Rating Score from 0 to 10 points
Postoperative static pain at 6 hours after block6 hours after the blockPain evaluated in Numeric Rating Score from 0 to 10 points
Time until first morphine demand48 hours after the blockTime until first patient-controlled analgesia morphine demand
Block assessment at 3 hours3 hours after the blockSensorimotor block assessed using a 10-point composite score evaluating sensory block of the lateral femoral cutaneous, femoral and obturator nerves, and motor block of femoral and obturator nerves. Sensation will be assessed with ice on then lateral, anterior and medial thigh using a 0 to 2 point scale. 0= no block, patients can feel cold; 1= analgesic block, patient can feel touch but not cold; 2= anesthetic block, patient cannot feel cold or touch. Motor function will be assessed for each nerve with a 0 to 2 points scale where 0= no motor block; 1= paresis; 2= paralysis.
Block assessment at 6 hours6 hours after the blockSensorimotor block assessed using a 10-point composite score evaluating sensory block of the lateral femoral cutaneous, femoral and obturator nerves, and motor block of femoral and obturator nerves. Sensation will be assessed with ice on then lateral, anterior and medial thigh using a 0 to 2 point scale. 0= no block, patients can feel cold; 1= analgesic block, patient can feel touch but not cold; 2= anesthetic block, patient cannot feel cold or touch. Motor function will be assessed for each nerve with a 0 to 2 points scale where 0= no motor block; 1= paresis; 2= paralysis.
Block assessment at 24 hours24 hours after the blockSensorimotor block assessed using a 10-point composite score evaluating sensory block of the lateral femoral cutaneous, femoral and obturator nerves, and motor block of femoral and obturator nerves. Sensation will be assessed with ice on then lateral, anterior and medial thigh using a 0 to 2 point scale. 0= no block, patients can feel cold; 1= analgesic block, patient can feel touch but not cold; 2= anesthetic block, patient cannot feel cold or touch. Motor function will be assessed for each nerve with a 0 to 2 points scale where 0= no motor block; 1= paresis; 2= paralysis.
Incidence of block related adverse events3 hours after blockIncidence of adverse events related to nerve block (vascular puncture, local anesthetic systemic toxicity, epidural spread)
Incidence of opioid related adverse events48 hours after blockIncidence of adverse events related to opioid use (nausea/vomiting, pruritus, somnolence, respiratory depression)
Incidence of Inability to perform physiotherapy24 hours after the blockInability to perform physiotherapy due to pain (score more than 4 in Numeric Rating Score from 0 to 10 points) or motor blockade.
Surgical duration4 hoursTime between skin incision and closure
Readiness to discharge4 days after surgeryDays to be ready for discharge following physiotherapist criteria
Length of hospital stay7 days after surgeryLength of hospital stay after surgery
Postoperative dynamic pain at 48 hours after block48 hours after the blockPain evaluated in Numeric Rating Score from 0 to 10 points

Countries

Chile

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026